6Calhoun DA,Jones D,Textor S,et al.Resistant hypertension:diagnosis,evaluation,and treatment:a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J].Hypertension,2008;51(6):1403-19.
7The ALLHAT officers and coordinators for the ALLHAT collaborative research group.Major outcomes in high risk hypertensive patients randomized to ACE inhibitor a calcium channel Blocker vs Diuretic-The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002;288(23):2981-97.
8Berl T,Hunsicker LG,Lewis JB,et al.Irbesartan Diabetic Nephropathy Trial.Collaborative Study Group.Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy[J].Ann Intern Med,2003;138(7):542-9.
9Wild S,Roglic G,Green A,et al.Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J].Diabetes Care,2004;27(5):1047-53.
10Kearney PM,Whelton M,Reynolds K,et al.Global burden of hypertension:analysis of worldwide data[J].Lancet,2005;365(15):217-23.
